These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21597931)

  • 1. Current management of symptomatic intracranial stenosis.
    Taylor RA; Weigele JB; Kasner SE
    Curr Atheroscler Rep; 2011 Aug; 13(4):321-9. PubMed ID: 21597931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of symptomatic intracranial stenosis: medical versus endovascular therapy.
    Weigele JB; Taylor RA; Kasner SE
    Curr Atheroscler Rep; 2007 Oct; 9(4):296-304. PubMed ID: 18173957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial angioplasty and stent placement for cerebral atherosclerosis.
    Schumacher HC; Khaw AV; Meyers PM; Gupta R; Higashida RT
    J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 2):S123-32. PubMed ID: 15101521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary prevention after ischemic stroke].
    Baumgartner RW; Georgiadis D
    Praxis (Bern 1994); 2003 Jan; 92(5):168-78. PubMed ID: 12643070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of intracranial arterial stenosis.
    Taylor RA; Kasner SE
    Expert Rev Neurother; 2006 Nov; 6(11):1685-94. PubMed ID: 17144782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.
    Turan TN; Cotsonis G; Lynn MJ; Wooley RH; Swanson S; Williams JE; Stern BJ; Derdeyn CP; Fiorella D; Chimowitz MI
    Cerebrovasc Dis; 2014; 37(3):203-11. PubMed ID: 24557055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Actual review of diagnostics and endovascular therapy of intracranial arterial stenoses].
    Gizewski ER; Weber R; Forsting M
    Rofo; 2011 Feb; 183(2):104-11. PubMed ID: 20972933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of intracranial atherosclerotic stenosis.
    Turan TN; Chimowitz MI
    Rev Neurol Dis; 2008; 5(3):117-24. PubMed ID: 18838951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular treatment of intracranial stenosis.
    Fiorella D
    World Neurosurg; 2011 Dec; 76(6 Suppl):S66-70. PubMed ID: 22182273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenge of stroke prevention with intracranial arterial stenosis.
    Turan TN; Smock A; Chimowitz MI
    Curr Cardiol Rep; 2013 Dec; 15(12):422. PubMed ID: 24105641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with symptomatic intracranial atherosclerosis.
    Leung TW; Kwon SU; Wong KS
    Int J Stroke; 2006 Feb; 1(1):20-5. PubMed ID: 18706064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Symptomatic Intracranial Stenosis.
    Hoak DA; Lutsep HL
    Curr Cardiol Rep; 2016 Sep; 18(9):83. PubMed ID: 27443379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lipid-lowering therapy on the progression of intracranial arterial stenosis.
    Tan TY; Kuo YL; Lin WC; Chen TY
    J Neurol; 2009 Feb; 256(2):187-93. PubMed ID: 19271101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular management of intracranial atherosclerosis.
    Teleb MS; Asif K; Castonguay AC; Zaidat OO
    Neurosurg Clin N Am; 2014 Jul; 25(3):593-605. PubMed ID: 24994093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What are the therapeutic options for strokes secondary to intracranial large artery stenosis?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Feb; 61(2):194-5. PubMed ID: 21375179
    [No Abstract]   [Full Text] [Related]  

  • 17. High risk of recurrent ischemic events among patients with deferred intracranial angioplasty and stent placement for symptomatic intracranial atherosclerosis.
    Kozak O; Tariq N; Suri MF; Taylor RA; Qureshi AI
    Neurosurgery; 2011 Aug; 69(2):334-42; discussion 342-3. PubMed ID: 21430591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factor profile and anatomic features of previously asymptomatic patients presenting with carotid-related stroke.
    Klarin D; Cambria RP; Ergul EA; Silverman SB; Patel VI; LaMuraglia GM; Conrad MF; Clouse WD
    J Vasc Surg; 2018 Nov; 68(5):1390-1395. PubMed ID: 29804741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease.
    Lee SP; Suh JW; Park KW; Lee HY; Kang HJ; Koo BK; Chae IH; Choi DJ; Rha SW; Bae JW; Cho MC; Kwon TG; Bae JH; Kim HS;
    Trials; 2010 Aug; 11():87. PubMed ID: 20735821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study.
    Dumont TM; Kan P; Snyder KV; Hopkins LN; Siddiqui AH; Levy EI
    Neurosurgery; 2012 Dec; 71(6):1103-10. PubMed ID: 22986593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.